| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |